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Abstract
Background: 46 U.S. states and the District of Columbia have passed laws and regulations mandating that health 
insurance plans cover diabetes treatment and preventive care. Previous research on state mandates suggested that 
these policies had little impact, since many health plans already covered the benefits. Here, we analyze the contents of 
and model the effect of state mandates. We examined how state mandates impacted the likelihood of using three 
types of diabetes preventive care: annual eye exams, annual foot exams, and performing daily self-monitoring of blood 
glucose (SMBG).
Methods: We collected information on diabetes benefits specified in state mandates and time the mandates were 
enacted. To assess impact, we used data that the Behavioral Risk Factor Surveillance System gathered between 1996 
and 2000. 4,797 individuals with self-reported diabetes and covered by private insurance were included; 3,195 of these 
resided in the 16 states that passed state mandates between 1997 and 1999; 1,602 resided in the 8 states or the District 
of Columbia without state mandates by 2000. Multivariate logistic regression models (with state fixed effect, 
controlling for patient demographic characteristics and socio-economic status, state characteristics, and time trend) 
were used to model the association between passing state mandates and the usage of the forms of diabetes 
preventive care, both individually and collectively.
Results: All 16 states that passed mandates between 1997 and 1999 required coverage of diabetic monitors and strips, 
while 15 states required coverage of diabetes self management education. Only 1 state required coverage of periodic 
eye and foot exams. State mandates were positively associated with a 6.3 (P = 0.04) and a 5.8 (P = 0.03) percentage 
point increase in the probability of privately insured diabetic patient's performing SMBG and simultaneous receiving all 
three preventive care, respectively; state mandates were not significantly associated with receiving annual diabetic eye 
(0.05 percentage points decrease, P = 0.92) or foot exams (2.3 percentage points increase, P = 0.45).
Conclusions: Effects of state mandates varied by preventive care type, with state mandates being associated with a 
small increase in SMBG. We found no evidence that state mandates were effective in increasing receipt of annual eye or 
foot exams. The small or non-significant effects might be attributed to small numbers of insured people not having the 
benefits prior to the mandates' passage. If state mandates' purpose is to provide improved benefits to many persons, 
policy makers should consider determining the number of people who might benefit prior to passing the mandate.
Background
In 2005, diabetes, both diagnosed and non-diagnosed,
affected nearly 21 million Americans. The number of
Americans with diabetes has risen steadily and is gener-
ally expected to further increase during the next several
decades [1]. Diabetes is associated with increased risk of
coronary heart disease, stroke, end-stage renal disease,
amputation, and blindness. During 2007, the direct medi-
cal cost related to diabetes in the United States was 116
billion dollars [2]. Preventive care, such as self monitoring
of blood glucose (SMBG), annual eye exams, and annual
foot exams, can prevent or delay the complications of dia-
betes and may subsequently reduce the associated health
care costs[3-5]. According to a 2006 national study, how-
ever, many Americans with diabetes did not perform
SMBG or receive annual eye or foot exams [6].
By 2009, the District of Columbia and all states except
Alabama, Idaho, North Dakota and Ohio had passed laws
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or regulations mandating that private insurance policies
include certain benefits for diabetes, such as coverage of
diabetic medication, equipment and supplies[7,8].
Although the number of state mandated benefit laws has
increased dramatically since the 1990s [9], few studies
have evaluated the efficacy of these mandates. For those
state mandates evaluated, studies often reported limited
effects, since many benefits mandated had already been
covered by the insurance polices [9-11].
The purpose of our study was to evaluate the effect of
the state diabetic benefit mandates on three forms of dia-
betes preventive care described in Healthy People 2010
objectives (SMBG, foot exams, eye exams). After gather-
ing data on the contents of state mandates (methods
described later), we hypothesized that:
(1) State mandates would have very limited national-
level direct effect (through expanding number of people
having covered benefits) on increasing the proportion of
people with diabetes receiving annual eye exams and
annual foot exams, since only one state mandated cover-
age of these forms of care.
(2) State mandates may have a positive direct effect on
SMBG; however, the size of this effect would depend on
how many insurance policies already covered diabetic
monitors and strips before the mandates.
(3) State mandates could indirectly increase receipt of
preventive care through increased knowledge obtained
via diabetes self management education (DSME) classes,
which were covered by many states' mandates.
We examined these relationships in a quantitative man-
ner.
Methods
Describing the Benefits that State Mandates Covered
We gathered from state websites information on state
mandates, such as benefits covered and the year the man-
dates were enacted. We also contacted state insurance
commissioners' offices or state legislatures to confirm
that the websites included all relevant data. We made a
checklist of covered benefits based on the typical benefits
covered in private insurance policies in the Model Con-
tract Specifications for Services Related to Diabetes[12].
We also validated the information using National Confer-
ence of State Legislations [8] and Government Account-
i n g  O f f i c e  ( G A O )  [ 1 3 ]  r e p o r t  o f  s t a t e  m a n d a t e s  o n
diabetes benefits. In this study, only benefits directly
related to receiving SMBG, eye exams, and foot exams are
considered.
Study Population and Data Source
We obtained data on the use of diabetes preventive care,
diabetes patients' demographic characteristics, and socio-
economic status from the publically available Behavioral
Risk Factor Surveillance System (BRFSS). The BRFSS
conducts annual, state-based, cross-sectional, random,
land-based telephone surveys of 150,000-210,000 com-
munity-dwelling U.S. adults. The BRFSS survey includes
a core questionnaire gathering basic information about
respondents' access to care and demographic characteris-
tics, and state-added modules for special topics, such as
diabetes. All states administer the core questionnaire
annually, but not all states administer the diabetes mod-
ule every year [14]. We used data from 1996-2000,
because relatively detailed insurance questions were
asked during those years. We excluded data from states
that passed mandates prior to 1996 (no pre-mandate data
would be available) or passed mandates in 2000 (no post-
mandate data would be available) or, if a mandate was
passed, had no diabetes data either the year before the
mandate, the year of the mandate, or the year after the
mandate. Restricting our analyses to the 24 remaining
states and District of Columbia, 16 of which passed man-
dates during our study period, formed a natural experi-
ment, allowing pre- and post-mandate comparisons.
Our total sample consisted of 4,797 adults with diag-
nosed diabetes who had private insurance and were of age
< 65 years (thus excluding the overwhelming majority of
those covered by Medicare) at the time of the interview.
The state median survey response rate during the study
period (Council of American Survey Research Organiza-
tions' definition) varied by year and ranged from 48.9% to
63.2% [15].
Diabetes Preventive Care Measures
We focused on three diabetes preventive care measures,
derived from the national goals on diabetes in Healthy
People 2010 [16]. These were: receiving a dilated eye
exam within the previous year; receiving a foot exam
within the previous year; and performing SMBG at least
once daily. Since all these are important for diabetic
patients, we also considered a fourth measure: simultane-
ously receiving all three.
State Mandates Variables
We created a dichotomous variable to distinguish years
before the mandate was enacted from the year the man-
date was enacted and subsequent years. This variable
indicates the calendar years that a mandate was/was not
in place; its value varied by state. For states that did not
enact a mandate, this variable was constant. This was our
primary independent variable of interest, since a positive
association between this variable and a given dependent
variable would suggest that the mandates were effective.
We did not distinguish among states by contents of man-
dated coverage, since almost all states' legislation man-
dated DSME and diabetes equipment and supplies. We
also did not consider how the effects of the mandates var-
ied among states because we wanted to estimate the aver-Li et al. BMC Health Services Research 2010, 10:133
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age effect over all states and not simply identify within-
state effects.
Covariates
We considered both state and individual-level covariates.
State covariates included: a state fixed effect to control for
the state time-invariant characteristics; percentage of
patients having at least one doctor visit last year (proxy
for physician supply and quality of care in the state); and
percentage of residents in the state with diagnosed diabe-
tes (since states having high diabetes prevalence rate may
be more likely to pass the mandates to improve the qual-
ity of care and reduce the costs of diabetes). Individual
level covariates included: patient age, gender, race/ethnic-
ity, marital status, education, income, time since diagno-
sis of diabetes, and insulin use.
We included 4 dichotomous variables indicating year
(1997, 1998, 1999, and 2000) to account for secular trend;
this controlled for the other national policies that affected
the utilization of diabetes preventive care, such as The
National Committee for Quality Assurance (NCQA)
requirements.
Statistical Methods
We conducted a person-level analysis. We used multivar-
iate logistic regression models, with dependent variables:
receipt of a dilated eye exam within the previous year;
receipt of a foot exam within the previous year; perform-
ing daily SMBG; and all three simultaneously. We report
both predicted marginal probabilities and odds ratios. We
used STATA software (version 10.1, StataCorp LP 2009),
accounting for the BRFSS's complex design. Results were
considered significant if p < 0.05.
Sensitivity Analyses
It is plausible that those with low income, non-Hispanic
blacks, and Hispanics with insurance are more likely than
others to have policies that did not cover the mandated
benefits before the state mandates [17-20]; the mandates
may disproportionately increase these persons' access to
care. We tested for interactions between having/not hav-
ing mandates and income and between mandates and
membership in racial/ethnic groups. Since insulin users
generally monitor blood glucose more frequently than
non-users, thereby using more test strips, we did a sub-
group analysis on SMBG for non-insulin users. In addi-
tion, regulations and laws may not take effect immedi-
ately. We therefore constructed a series of lag variables to
capture the effect of mandates at different time after
enactment: instead of one dichotomous variable, the lag
variables included four dichotomous variables: the year
the mandate enacted; the first year after enactment; the
second year after enactment; and the third year after
enactment. We tested the null hypothesis that all the four
coefficients were the same.
Results
Description of State Mandates
Table 1 lists the states in our analysis and the year man-
dated insurance coverage on diabetes care benefits took
effect. Sixteen states enacted mandates between 1997 and
1999 (3 in 1997; 9 in 1998, and 4 in 1999). Eight states and
the District of Columbia did not have mandates as of
2000. Specific benefits covered by the mandates varied
among states. Among the states with a mandate, all
except Arizona mandated insurance coverage of DSME.
All states mandated coverage of diabetic equipments and
supplies; only Texas covered periodic eye and foot exams.
Characteristics of the States and the Patients
Table 2 describes the state characteristics and patient
characteristics in the states that passed mandates and in
the states not having mandates. The two groups of states
did not differ significantly in most of the characteristics
except that states that enacted mandates had: a higher
proportion of Non-Hispanic Whites; a smaller propor-
tion of the population of other race/ethnicities; and a
slightly higher proportion of younger adults. The average
state prevalence of diabetes was 5.5%; 30% of the people
with diabetes used insulin; the mean time since detection
of diabetes was 8.8 years. 90% had at least a high school
education; 12% has annual family income more than
$75,000 in the year prior to the interview.
Time Trends in the Utilization of Preventive Care Services at 
the State Level
Figure 1 displays the unadjusted rates of diabetic patients
receiving three preventive care over time in the states that
Table 1: Year in which mandates on diabetes took effect in 
the states included in the study
Year Mandated Coverage 
Took Effect
State
1997 Arkansas, Nevada, 
Tennessee,
1998 Colorado, Georgia, Kansas, 
Kentucky, Mississippi, New 
Hampshire, North Carolina†, 
Texas†, Vermont,
1999 Arizona, Iowa, Pensylvania, 
Virginia
Not having mandates as of 
the end of 2000
Alabama, District of 
Columbia†, Hawaii, Idaho, 
Michigan, Montana, North 
Dakota, Ohio, Wyoming
Alabama, Idaho, North Dakota, and Ohio had not passed 
mandates as of 2009
†In these states, the laws became effective later than August of 
the year, so in the analysis, the effective year was coded as the 
following yearLi et al. BMC Health Services Research 2010, 10:133
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enacted mandates in 1997, 1998 or 1999, and in those
states not having mandates. Panels A-D show, respec-
tively, performing daily SMBG (A), receiving annual eye
exam and foot exams (B and C), and receiving all three
preventive care simultaneously (D). The rates of patients
performing SMBG and receiving eye and foot exams
increased in both those states enacted mandates and
those not having mandates except in 1998. In that year,
there was a dip in the charts for all non-mandate states,
while in states with mandates, the slopes were all positive.
The trend lines for performing daily SMBG and receiving
all three preventive care in the states that enacted man-
dates were slightly steeper than the corresponding lines
in the states not passing mandates (trend lines not
shown).
Effects of State Mandates on the Utilization of Diabetes 
Preventive Care
Additional File 1 shows the predicted marginal probabili-
ties and odds ratios of the legal variables and control vari-
ables on the use of diabetes preventive care measures
considered. After controlling for the state level character-
istics, patient diabetes treatment and time since diagno-
sis, and socio-economic and demographic characteristics,
on average, state mandates were associated with: a 6.3
percentage point increase in the probability of patients
performing daily SMBG (odds ratio, 1.3, P = 0.04); a 0.1
(rounded) percentage point decrease in the probability of
receiving annual eye exams (odds ratio, 1.0, P = 0.92, not
significant); a 2.3 percentage point increase in the proba-
bility of receiving annual foot exams (odds ratio, 1.1, P =
0.45, not significant); and a 5.8 percentage point increase
in the probability of the patient receiving all three types of
preventive care (odds ratio, 1.4, P = 0.03).
State and Personal Characteristics Associated with 
Utilization of Diabetes Preventive Care Services
Insulin users were 40.7, 13.5, 21.3 and 27.1 percentage
points (predicted probabilities) more likely to perform
daily SMBG, receive annual eye exams, receive foot
exams, and receive all three preventive care simultane-
ously, respectively. Non-Hispanic blacks were 6.2,12.5,
and 6.6 percentage point more likely to receive annual eye
exams, foot exams, and all three forms of preventive care.
Table 2: Comparison of state and person-level characteristics between the states that enacted mandates and those not 
having mandates
States mandates enacted during 1997 
and 1999
(N = 3195)
Mean(95% CIs*)
States not having mandates as of 2000
(N = 1602)
Mean(95% CIs*)
Rate of patients having doctoral visits last 
year (%)
87.8(87.6, 87.9) 87.4(87.2, 87.6)
Prevalence of diabetes in the state (%) 5.5(5.5, 5.5) 5.4(5.4, 5.5)
Insulin use among people with diabetes (%) 30.7 (29.1, 32.3) 29.2 (27.0, 31.4)
Time since diagnosis of diabetes (years) 8.7(8.4,9.0) 8.8(8.4,9.3)
Male (%) 45.9 (44.2, 47.7) 46.6 (44.2, 49.1)
Married (%) 65.7 (64.1, 67.4) 63.7 (61.3, 66.1)
Aged 18-44 y (%) 29.8 (28.2, 31.3) 26.1 (23.9, 28.3)
Aged 45-64 y (%) 70.0 (68.5, 71.6) 73.9(71.7, 76.1)
Non-Hispanic White (%) 78.9 (77.5, 80.3) 71.1 (68.9, 73.3)
Non-Hispanic Black (%) 12.4 (11.3,13.6) 12.5 (10.9,14.1)
Hispanic (%) 6.3 (5.4, 7.1) 4.7 (3.6, 5.7)
Other race/ethnicity (%) 2.4(1.9, 3.0) 11.7(10.2, 13.3)
Less than high school education (%) 10.1 (9.1,11.2) 8.7 (7.4,10.1)
High school graduate (%) 34.1 (32.5, 35.8) 32.4 (30.1, 34.7)
Some college but did not graduate (%) 28.6 (27.0, 30.2) 30.3 (28.1, 32.6)
College graduate (%) 27.1 (25.6,28.6) 28.5(26.3,30.7)
Family income <$35,000/y (%) 46.9 (45.2, 48.7) 44.3 (41.8, 46.7)
Family income $35,000-$75,000/y(%) 41.5 (39.8,43.2) 43.2 (40.8,45.6)
Family income >$75,000/y (%) 11.5 (10.4,12.7) 12.5 (10.9,14.2)
*: CIs: Confidence intervalsLi et al. BMC Health Services Research 2010, 10:133
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Persons who completed high school or greater had signif-
icantly higher probabilities of using all three forms of pre-
ventive care, separately or simultaneously (Additional File
1).
Results for the Sensitivity Analysis
The coefficients of the interaction terms between man-
date effect and the indicators for being non-Hispanic
black or Hispanic were positive for all dependent vari-
ables, but none were significant. For the low income
group, the coefficients were positive for performing
SMBG, and none were significant. The coefficients of the
variable indicating years after the mandates were passed
in the sub-group analysis on non-insulin users were simi-
lar to the corresponding coefficients in the base case;
none were significant. The null hypothesis that the vari-
ables showing the lag effects were the same was not
rejected. For brevity, we do not show these specific
results.
Discussion
To the authors' knowledge, this is the first national level
study of the impact of state mandatory diabetes insurance
coverage on the use of diabetes preventive care. Our find-
ings suggest that state mandates vary in their impact by
preventive care type, but the impact tends to be small.
The effects of state mandates were smaller than other
policies expanding insurance coverage for patients with
diabetes. Li et al. analyzed the effect of the Medicare
expansion on diabetes monitors and strips to non-insulin
users in 1997; the probability of diabetes non-insulin
users' performing daily SMBG increased by 6-16 percent-
age points after the expansion [21]. Karter et al. reported
a 16 percentage point increase in performing daily SMBG
Figure 1 Trends in the Rates of Receipt of Three Forms of Preventive Care in the States that Enacted Mandates in 1997, 1998, or 1999 and 
States not Having Mandates as of 2000.
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and an 8 percentage point increase in annual eye exams
among diabetes patients in a large managed care organi-
zation after it changed its reimbursement policy from no
coverage to only paying a small amount of copayment for
strips and eye exams [22].
One possible reason for the limited effect of mandates
is that many insurance policies already covered the man-
dated benefits even without mandates in place; accord-
ingly a relatively small number of people were directly
benefitted. As an extreme example, a 2003 report by the
Utah Insurance Department showed that, prior to the
passage of Utah's 2000 law requiring insurers to cover
diabetic monitors and blood testing strips, all insurance
plans in the state already provided such coverage [23].
Although self-insured health plans were exempt from the
mandates, a GAO report (2005) showed that the policies
in 13 of the largest employers self-insured health plans
covered most of the mandated benefits [13]. We are
aware of no evidence that the benefit coverage of the self-
insured health plans are more generous than the other
private insurance policies, which the state mandates
would impact. The GAO report also attributed the small
number of states mandating periodical eye and foot
exams to these forms of care being considered part of
general health care, and therefore already covered [13].
Another possible reason for the limited effect is that
unpublished work from the CDC indicates that 30%-50%
of Americans with diabetes work for employers that are
exempted from state mandates (self-insured organiza-
tions or the federal government); however, our data
source does not allow us to identify these people. Consid-
ering the larger size of the effect of similar mandates in
the Medicare population, we would probably have found
larger effects here had our data sources allowed us to
restrict our analyses to those whose employers were sub-
ject to state mandates and whose insurance did not cover
these preventive care before the mandates [21].
The state mandates were not shown to have an effect
on annual eye and foot exams, which was consistent with
our hypothesis that the direct effect of state mandates
would be limited. However, we also found no evidence for
the hypothesized indirect effects through increased
knowledge. One possible explanation is that annual eye
and foot exams, unlike SMBG, require more effort from
health providers than from the patients, and state man-
dates do not directly affect providers' practice pattern,
although the mandates reduced the burden of filing
paperwork claiming authorization[24]. Ceiling effects
may also play a role: 63% and 59% percent of patients had
received annual eye exams and foot exams before the
state mandates, respectively, while only 44% performed
SMBG daily. The effect of expanding insurance coverage
in further increasing the proportion of patients receiving
annual eye exams and foot exams might be limited. Other
strategies might be considered.
Direct (mandating benefit coverage) and indirect (the
effect achieved through increased knowledge obtained
via DSME) effects could not be isolated, and our data did
not allow us to determine whether the expanded DSME
coverage actually resulted in an increase in patients tak-
ing DSME classes. All but one of the states that passed
mandates between 1997 and 1999 covered DSME. DSME
classes often include material concerning the importance
of performing SMBG and receiving annual eye and foot
exams to prevent diabetic complications [25]. Prior to the
mandates being passed, coverage of DSME was unusual.
For example, a study in 1994 reported that only 35.1% of
the US adult population with diabetes attended any dia-
betes classes or programs, primarily due to lack of reim-
bursement [26,27]. However, our results suggest that the
effects of DSME classes during the study period might be
limited. This could be due to how the mandates on DSME
were implemented: many mandates included restrictions
on who should receive the benefits and who could be
reimbursed for providing DSME [25]. Thus the benefits
of mandated coverage on DSME might not be realized in
the initial years after the mandates passed.
Members of racial and ethnic minorities and low
income persons could plausibly be more likely than oth-
ers to be underinsured, therefore, they might benefit
more from the mandates. When we examined interaction
terms between the variables indicating presence of a
mandate and the variables indicating membership in
these groups, the coefficients of the interaction terms
were positive. This suggested that the state mandates
might have had more effect on use of the preventive care
in people who were underinsured and less likely to have
these coverage before the state mandates. However, the
interactions were not significant. Because these sub-
groups were represented by small sample sizes, we had
little power to detect interactions. Thus, it remains
unknown if mandates are truly more effective in the case
of underinsured persons.
Our results show that state mandates increased the
probability of people with diabetes receiving all three
types of preventive care simultaneously. This is important
because diabetic patients need comprehensive care. From
the size of the coefficients, this could plausibly be due to
improved SMBG among people who received eye and
foot exams. It is possible that those who did not receive
annual eye or foot exams prior to the mandates (the
group that most needs to be motivated to receive preven-
tive care) were not motivated by changes in insurance
coverage.
Our study has several limitations. First, our results only
apply to the states included in the analysis and the three
types of preventive care. The results might or might notLi et al. BMC Health Services Research 2010, 10:133
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generalize to other states and other types of care, such as
DSME or prescription drugs. Second, we did not have
information on how state mandates were implemented.
Third, the cross-sectional nature of the data does not
allow us to make causal inferences. Fourth, if there were
other confounding state time-variant characteristics, our
estimation might be biased. Fifth, although we used time
trend to control the effects of national programs such as
NCQA report cards and other diabetes quality improve-
ment initiatives, if the effects of these programs differed
among the states, our results might be confounded.
Finally, our study also inherited the limitations of the
BRFSS. For example, BRFSS data are self-reported;
BRFSS is a land telephone-based surveillance system,
excluding those without land-based telephones.
Although state mandates might have improved receipt
of diabetes-related preventive care little or none, we do
not advocate that mandates be repealed. Following the
1990's shrinkage of benefits covered by managed care
health plans and the failure of the health care reform,
state mandates were more and more used as a political
force to push the problem in health care system onto the
policy agenda and show that government can take action.
One state's mandates can also serve as precedents for
others [9]. This symbolic effect can be very powerful:
during 1996-2003, 43 states and District of Columbia
passed state mandates on diabetes benefits. The early
state mandates may have contributed to the expansion of
Medicare's coverage of diabetes in 1997 [7]. Thus the
state mandates could contribute indirectly to the
improvement of the diabetes care, along with the other
programs such as NCQA quality report card and the state
diabetes prevention and control programs. In addition,
small increases in rate of utilization, over time, can add
up. Since we do not know what happened after our study
period, it is possible that the small increase in performing
daily SMBG that we detected might, eventually, have a
positive impact on public health. Furthermore, oppo-
nents of state mandates have claimed that mandates
would increase insurance premiums, causing employers
to drop insurance and leave more people uninsured[28].
Our analysis showed that state mandates had a small
impact on using the covered benefits. Thus, it is unlikely
that more than a handful of employers would drop insur-
ance coverage due to state mandates.
Conclusions
Our study provided the first large-scale evaluation of effi-
cacy of state mandates on diabetes benefits. Further stud-
ies should collect data on the specific coverage provided
to patients in different health plans in the states over
time, and expand the health services and outcome mea-
sures considered in this study. This would support evalu-
ation of policy effects on those that state mandates truly
affected, either directly or indirectly. In addition, cost-
benefit analyses, incorporating administrative costs,
added costs for using the services, and the benefits from
using more preventive care, should be a part of future
decision making on state mandates. The primary conse-
quence of this study (the small effects of the mandates)
can be paraphrased as "small increases in benefits are
likely to have small effects". If the purpose of state man-
dates is to provide improved benefits to many persons,
state policy makers in states that do not do so should
determine the number of people a mandate would benefit
prior to passing the mandate. The new health care reform
will expand coverage to 32 million uninsured people and
mandate coverage of recommended preventive services
with no cost sharing [29,30]. Following the same ratio-
nale, this could plausibly increase in the use of preventive
services, particularly among the previously uninsured.
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